Federal government yesterday alerted Nigerians on circulation of two confirmed falsified versions of Quinine Sulphate in Cameroon and the Democratic Republic of the Congo.
It said the falsified drugs contain zero active pharmaceutical ingredients.
It explained that though there is no evidence of the falsified drugs in Nigeria, members of the public should report to the nearest office of The National Agency for Food and Drug Administration (NAFDAC) if the drugs are spotted anywhere, including hospitals and pharmaceutical shops.
Red alert was contained in a statement by Director of Press and Public Relations, Federal Ministry of Health, Mrs. Boade Akinola.
She said Quinine Sulphate is used for the treatment of Falciparum Malaria in the region, meaning it will not be effective and may lead to other health challenges.
Akinola explained: “These products, which were initially discovered by a local NGO, failed the preliminary field screening and were submitted to a WHO pre-qualified Quality Assurance laboratory.
“Subsequent analysis showed that neither product contained any of the stated active pharmaceutical ingredients.
“If you are in possession of these products, please do not use them.
“If you have taken this falsified product or suffer an adverse effect following its uptake, please seek immediate advice from a qualified healthcare professional and report the incident to NAFDAC.”
She assured government has stepped up vigilance within the drug supply chains in the country. Numbers to contact are: +234-8037881120; +234-8055o56727; +234-8035902679.
“Details of the product are shown below
1) Product Name Quinine Sulfate 300 mg Number of Tablets per container 1000 Batch Number 10H05 Expiry Date 09/2018 Date of manufacture 09/2014 Manufacturer Novadina Pharmaceutical Ltd, London, United Kingdom.
2) Product Name Quinine Sulphate 300mg Number of Tablets per container 100 Batch Number F4387 Expiry Date 11/18
Date of manufacture 12/14 Manufacturer CAD Pharm, India”
No comments:
Post a Comment